title: Human immunodeficiency virus-related lipoatrophy of the face: where should we have to fill?
authors: Unit of Maxillofacial Surgery, Head and Neck Department, II University of Naples (Rauso, Tartaro) General Pathology Department, II University of Naples (Cobellis) Infective Disease Department, Cotugno Infective Disease Hospital (Sangiovanni) Unit of Maxillofacial Surgery, Head and Neck Department, II University of Naples, Naples, Italy (Colella).
authors: Raffaele
authors: R
authors: Rauso
authors: Gianpaolo
authors: G
authors: Tartaro
authors: Gilda
authors: G
authors: Cobellis
authors: Vincenzo
authors: V
authors: Sangiovanni
authors: Giuseppe
authors: G
authors: Colella
references: Paton NI, Yang Y, Tha NO, Sitoh YY. Changes in facial fat in HIV-related lipoatrophy, wasting, and weight gain measured by magnetic resonance imaging. HIV Clin Trials 2007;8:227–234.
references: Davison SP, Timpone J Jr, Hannan CM. Surgical algorithm for management of HIV lipodystrophy. Plast Reconstr Surg. 2007;120:1843–1858.
references: Mori A, Lo Russo G, Agostini T, Pattarino J, Vichi F, Dini M. Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants. J Plast Reconstr Aesthet Surg. 2006;59:1209–1216.
references: Claude O, Domergue Than Trong E, Blanc R, et al. Treatment of HIV facial lipoatrophy with a submalar porous polyethylene implant (Medpor) (in French). Ann Chir Plast Esthet. 2009;54:21–28.